Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina
about
Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke.
P2860
Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Optimizing the Economic Impact ...... te: The Case of South Carolina
@ast
Optimizing the Economic Impact ...... te: The Case of South Carolina
@en
Optimizing the Economic Impact ...... te: The Case of South Carolina
@nl
type
label
Optimizing the Economic Impact ...... te: The Case of South Carolina
@ast
Optimizing the Economic Impact ...... te: The Case of South Carolina
@en
Optimizing the Economic Impact ...... te: The Case of South Carolina
@nl
prefLabel
Optimizing the Economic Impact ...... te: The Case of South Carolina
@ast
Optimizing the Economic Impact ...... te: The Case of South Carolina
@en
Optimizing the Economic Impact ...... te: The Case of South Carolina
@nl
P2093
P2860
P1476
Optimizing the Economic Impact ...... te: The Case of South Carolina
@en
P2093
Abby Swanson Kazley
Annie Simpson
Edward Jauch
Kit N Simpson
Robert J Adams
P2860
P304
P407
P577
2013-05-01T00:00:00Z